Professor Erika Lietzan recently gave a lecture on the Hatch-Waxman Amendments as part of the Mason Judicial Education Program, a division of George Mason University’s Law & Economics Center (LEC). Professor Lietzan lectured for an hour on the Hatch-Waxman Amendments, which created a statutory pathway for approval of generic drugs as well as provisions governing the timing of that approval and special litigation provisions for drug patent disputes.
Professor Lietzan specialized on this framework while in private practice (for 18 years, most of them at Covington & Burling in DC) and recently published a comprehensive assessment of the history and political economy of the amendments in the Seton Hall Law Review. At Mizzou Law, she teaches both FDA law and intellectual property law.
The Mason Judicial Education Program is one of the nation’s preeminent providers of high-quality, balanced judicial education seminars and conferences. The 2019 symposium, The Legal, Economic, and Regulatory Environment of the Pharmaceutical Industry was held April 14-16 at the George Mason University Antonin Scalia Law School.